# The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment

> **NCT07423637** · NA · NOT_YET_RECRUITING · sponsor: **Helsinki University Central Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DEVICE:** Omnipod 5
- **DRUG:** Multiple daily injections of insulin

## Key facts

- **NCT ID:** NCT07423637
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-09-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07423637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07423637, "The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07423637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*